COMP <GO>
SGP vs AORT // GROSS PROFIT MARGIN
SpyGlass Pharma Inc. (NASDAQ) VS. Artivion Inc. (NYSE) • 15-METRIC TALLY: SGP 1
— AORT 4
■ METRIC PARITY
LAST: $32.51 (-1.06%) • MKT CAP: $1.09B
gross-margins
—
LAST: $23.44 (+2.27%) • MKT CAP: $1.14B
gross-margins
64.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SGP VS. AORT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SGP | AORT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | 64.40% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 4.50% | -39.50 | AORT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 19.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.08% | 0.07% | -3.15 | AORT | /fcf-yield <GO> |
| Operating Margin | — | 7.60% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 2.20% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 13.60% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 2.46 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 9/9 | -7.00 | AORT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 71.4 | 46.6 | +24.81 | SGP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 98.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.09B | $1.14B | -$55.5M | AORT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SGP REV | AORT REV | SGP GROSS % | AORT GROSS % | SGP FCF | AORT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $441.3M | — | 64.4% | -$33.5M | $839.0K |
| FY 2024 | $0 | $388.5M | — | 64.0% | -$24.0M | $11.0M |
| FY 2023 | — | $354.0M | — | — | — | $18.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SGP // BETA —
AORT // BETA —